Fundraising FoxNeurophyxia
s-Hertogenbosch, NL · 1 known investors
Find your way into Neurophyxia
Sign up to see every warm intro you have to Neurophyxia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurophyxia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neurophyxia is developing a neuroprotectant compound (2-iminobiotin) for treating brain injury and tissue damage caused by stroke, cardiac arrest, and birth asphyxia. The compound is in Phase IIb/III clinical development.
Investors · 1
Frequently asked questions
- What does Neurophyxia do?
- Neurophyxia is developing a neuroprotectant compound (2-iminobiotin) for treating brain injury and tissue damage caused by stroke, cardiac arrest, and birth asphyxia. The compound is in Phase IIb/III clinical development.
- Who are Neurophyxia's investors?
- Neurophyxia's investors include Waterman Ventures.
- Where is Neurophyxia headquartered?
- Neurophyxia is headquartered in s-Hertogenbosch, NL.